127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2096

Simcere Pharmaceutical Group
HK$5.23-1.1%-45.9%HK$13.5bHK$8.41PE17.5xE24.3%3.3%

CVGU

CSPC Pharmaceutical Group
HK$2.74-5.5%-21.7%HK$70.4bHK$4.31PE11.1xE4.5%4.7%

2020

Zhejiang Jingxin Pharmaceutical
CN¥10.24-1.2%-34.0%CN¥8.8bn/aPE14.2xE14.9%2.9%

2096

Simcere Pharmaceutical Group
HK$5.23-1.1%-45.9%HK$13.5bHK$8.41PE17.5xE24.3%3.3%

1513

Livzon Pharmaceutical Group
CN¥25.201.2%-16.0%CN¥29.8bCN¥27.04PE18xE10.2%3.5%

1513

Livzon Pharmaceutical Group
CN¥25.502.4%-15.0%CN¥29.8bCN¥27.36PE18xE10.2%3.5%

0MH6

Ipsen
€110.302.1%3.7%€9.0b€125.65PE14.6xE6.0%1.1%

1093 N

CSPC Pharmaceutical Group
HK$15.690%-27.0%HK$69.4bHK$25.29PE10.4xE1.4%4.7%

APNH.F

Aspen Pharmacare Holdings
R9.210%25.9%R86.8bR9.62PE16.5xE17.8%1.8%

2020

Zhejiang Jingxin Pharmaceutical
CN¥10.25-1.1%-34.0%CN¥8.8bn/aPE14.2xE14.9%2.9%

CSPC.Y

CSPC Pharmaceutical Group
HK$2.94-5.2%-27.8%HK$70.4bHK$4.63PE11.1xE4.5%4.7%

SGIO.F

Shionogi
JP¥49.600%9.9%JP¥2.1tJP¥52.15PE13.5xE-0.6%2.0%

NPPN.Y

Nippon Shinyaku
JP¥7.710%-31.8%JP¥292.2bJP¥11.48PE11.9xE2.8%2.9%

719

Shandong Xinhua Pharmaceutical
HK$5.382.1%-18.1%HK$9.4bn/aPE6.8xn/a5.0%

719

Shandong Xinhua Pharmaceutical
HK$5.382.1%-18.1%HK$9.4bn/aPE6.8xn/a5.0%

2096

Simcere Pharmaceutical Group
HK$5.23-1.1%-45.9%HK$13.5bHK$8.41PE17.5xE24.3%3.3%

719

Shandong Xinhua Pharmaceutical
HK$5.361.7%-18.4%HK$9.4bn/aPE6.8xn/a5.0%

FFEA

Faes Farma
€3.142.4%0.5%€982.0m€3.69PE10.7xE-1.1%4.9%

CHJT.F

CSPC Pharmaceutical Group
HK$0.750%-23.8%HK$70.4bHK$1.18PE11.1xE4.5%4.7%

4516 N

Nippon Shinyaku
JP¥468.31n/an/aJP¥292.2bJP¥687.67PE12.1xE2.8%2.9%

300841

Chengdu Kanghua Biological Products
CN¥56.72-1.5%-43.7%CN¥7.6bCN¥103.14PE14.7xE17.4%3.6%

IPNP

Ipsen
€110.000%3.5%€9.0b€125.31PE14.6xE6.0%1.1%

1093

CSPC Pharmaceutical Group
HK$5.87-4.6%-27.9%HK$70.4bHK$9.35PE10.9xE4.5%4.8%

FAEE

Faes Farma
€3.200%-15.9%€1.0b€4.00PE10.9xE0.2%5.0%
Page 5 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.